Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Jan 9.
Published in final edited form as: Angew Chem Int Ed Engl. 2018 Nov 12;57(49):16083–16087. doi: 10.1002/anie.201810065

A Near-Infrared Photoswitchable Protein–Fluorophore Tag for No-Wash Live Cell Imaging

Wei Sheng 1, Setare Tahmasebi Nick 2, Elizabeth M Santos 3, Xinliang Ding 4, Jun Zhang 5, Chrysoula Vasileiou 6, James H Geiger 7,*, Babak Borhan 8,*
PMCID: PMC7796701  NIHMSID: NIHMS1657753  PMID: 30311335

Abstract

FR-1V, a fluorene-based aldehydic chromophore, binds its target protein as an imine to yield a highly bathochromic pigment, CF-2, a prototypic protein–dye tagging system whose NIR emission can be spatiotemporally switched ON by rapid UV-light activation. This is achieved through photoisomerization of the imine and its subsequent protonation. We demonstrate a no-wash protocol for live cell imaging of subcellular compartments in a variety of mammalian cell lines with minimal fluorescence background.

Keywords: confocal imaging, fluorene, NIR fluorescence, photoswitch, red-shifted fluorophores


Laser scan fluorescence microscopy (LSFM) is an indispensable tool for biological research,[1] which is largely due to the availability of appropriate fluorescent proteins (FPs).[2] FPs have an innate advantage as they can be genetically attached to proteins of interest (POIs) as fusion reporters to achieve extremely high labeling specificity. After decades of development, an arsenal of FPs is available with emissions that span almost the entire visible spectrum and possess high fluorescence brightness, giving end users a wide palette of choices. Recently, successful development of alternative phytochrome-based far-red/NIR FPs such as GAF-FP, iFPs, and iRFPs,[3] has extended the excitation/emission wavelengths into the NIR-I regime (700–900 nm)[4] such that deep-tissue fluorescence imaging becomes attainable. Another major advance has been the development of reversibly switchable FPs (RSFPs), such as Dronpa and Padron, with the ability to turn ON and OFF their fluorescence by light. These systems have led to applications in super-resolution microscopy (such as STORM/PALM).[5] Despite the many advantageous features, FPs do not always exhibit large Stokes shifts, are oxygen-dependent, and need time to mature. Furthermore, FPs may induce POI mislocalization.[6] With as many FPs developed thus far, it is difficult to integrate all these features, namely, far-red/NIR emission, large Stokes shift, photoswitchability, fast labeling kinetics, and small size, into a single variant.

In contrast to FPs, the photophysical properties of synthetic dyes are more tunable. A good example is the Janelia Fluors that have varied fluorescence lifetimes controlled as a result of changes in their twisted intramolecular charge transfer.[7] Combination of synthetic dyes with various post-translationally modifiable protein/peptide tags have led to the development of site-selective chemical labeling systems.[8] These include self-labeling enzymes (Halo, SNAP/ CLIP),[8] protein affinity ligands (Y-FAST, TMP and FAP),[8,9] bioorthogonal tags (CuAAC, SPAAC, IEDDA, and other click reactions),[10] or mixed approaches (LplA mediated PRIME,[11] biarsenical FlAsH/ReAsH,[12] and dicysteine tag dC10*).[13] These methods have greatly complemented FPs and have broadened the scope and utility of LSFM. Nonetheless, except for the biarsenics, the dC10* tags, and the PYP-tags,[14] these approaches generally use non-fluorogenic fluorochromes (that is, always ON), hence requiring wash steps after staining to remove excess dye to increase signal-to-background ratio (SBR). Current no-wash strategies are generally based on PeT (photoinduced electron transfer) quenched fluorogens and quenched activity-based probes (qABPs).[10,15] Successful examples include tetrazine-derived fluorogens,[16] which require the expression of chemically modified non-canonical amino acids to facilitate the fluorescence activation. The fluorogenic qABPs are larger in size than their parent emitters, and their effectiveness relies on enzymatic activity. Recently, environment-sensitive dyeincorporated probes have been explored. Nonetheless, they mainly rely on polarity change and lack labeling ubiquity.[17]

In this context, novel imaging tags, especially those that can incorporate multiple features into a single system, are in great demand. These features include: 1) high labeling specificity, to minimize nonspecific background; 2) far-red/ NIR emission, to obtain high tissue transparency; 3) high brightness, to increase image contrast; 4) large Stokes shift, to reduce self-quenching and further increase imaging depth; 5) high photostability, to prevent photobleaching; 6) ON/ OFF fluorogenicity, to enable spatiotemporal control; 7) fast labeling kinetics, to realize real-time imaging; 8) small size, to avoid perturbing target functionality; and 9) minimal cytotoxicity. It is reasonable to envision that the latter goals are achievable with the use of protein/fluorophore combination that has the proper photophysical/photochemical properties.

Previously, we have disclosed the use of engineered human cellular retinol binding protein II (hCRBPII) variants containing an active site lysine residue (Q108K) that reacts with synthetic aldehydic chromophores to form protonated (PSB) or neutral (SB) Schiff bases. hCRBPII is a small (15 kDa) cytosolic protein, belonging to the intracellular lipid binding protein family, and has high tolerance to mutations without affecting its structure.[18] These studies have led to a robust platform to design fluorescent complexes that have controlled emission profiles based on fluorophore-protein interactions. Similar to cis–trans isomerization observed in some RSFPs,[5] engineered CRABPII (cellular retinoic acid binding protein II), having a similar structure to hCRBPII but a deeper binding cavity, exhibited cis–trans imine isomerization of bound all trans-retinal in both solution and crystals.[19] As shown crystallograhically, the cis-iminium (PSB) is first formed, followed by thermal isomerization to the trans-imine (SB). It was further demonstrated in single crystals that the same cycle could be driven photochemically, with green light irradiation driving the cis-iminium to the trans-imine, and UV irradiation driving the photocycle in the opposite direction (Figure 1a, retinylidene chromophore). These observations inspired a search for a fluorophore-hCRBPII complex capable of recapitulating the imine/iminium photoisomerization, such that SB and PSB would have spectrally resolved absorption and emission peaks. We further speculated that the photochemical activation required for the PSB emission would suffice to make the complex fluorogenic in the confocal long-wavelength channel. Although other cellular proteins have the potential to bind the fluorophore as a SB, the photoisomerization event is specific to unique hCRBPII mutants, and thus non-specific SB formation with non-targeted proteins is of no concern with regards to generating undesired background emission. This should constitute a no-wash protocol for live cell imaging.

Figure 1.

Figure 1.

a) Representation of chromophore-hCRBPII/CRABPII photoisomerization cycle. The imines in the photocycle are the product of retinal or FR-1V, bound to their respective protein hosts, via imine formation with an active Lys residue (Lys111 of hCRABPII for retinal, and Lys108 of hCRBPII for FR-1V). Absorbance and emission spectra of CF-1 (complex of FR-1V with hCRBPII-Q108K/K40L/T51V/T53S/Y19W/R58Y hexamutant, psHex), b) OFF and c) ON states (at pH 7.3 in PBS buffer, excited at absorption maxima). d) Photoswitching fatigue resistance of CF-1 monitored at OFF and ON emission maxima. Alternate irradiation steps were illuminated using an Arc lamp (Hg(Xe), Oriel), with UV light (U-360 UV Bandpass filter) for 20 s, and yellow light (Y-50 500 nm Longpass filter) for 15 min, in non-degassed solutions. 0.6% absorption and 1% emission intensities were observed decreasing per cycle. e) Thermal (22°C) vs. yellow light-assisted (Y-50 filter) switching of CF-1 ON-to-OFF conversion, monitored at ON-state absorption maximum. Data points collected at 3 min interval. Absorbance and emission spectra of CF-2 (complex of FR-1V with psHex-Y58W/T29L/Q38L/Q128L, psNona), f) OFF and g) ON states (at pH 7.3 in PBS buffer, excited at absorption maxima).

To obtain large Stokes shift and long-wavelength emission, we synthesized dyes characterized by strong intramolecular charge transfer (ICT). In principle, ICT dyes are hyper-sensitive to changes in the local environment, owing to the highly polar nature of their excited states. The net result is that environmental polarity induces a wavelength shift in emission rather than absorption, leading to a large Stokes shift. The FR0 dye was first selected due to its strong ICT nature and exceptionally high fluorescence quantum yield.[20] FR0 derivatives with extended conjugation between the fluorene and the aldehyde were synthesized to shift the emission wavelengths further to the red end. Prior to in vitro studies, we used n-butylamine as a surrogate for lysine to form SB with the derivatives and screen for the fluorophore with proper spectroscopic features. FR-1V (1V denoting one vinyl group) was selected because of its strong environmental response and high brightness (Supporting Information, Figure S1 and Table S1). To shift the emission wavelength even redder, the SB was acidified to obtain the PSB, further minimizing the HOMO–LUMO energy gap. Gratifyingly, the PSB emission maximum was in the NIR-I region (Supporting Information, Figure S2).

In search of an optimal protein for imaging purposes, we carried out site-directed mutagenesis of residues within 4 Å of the chromophore, based on a retinal-bound hCRBPII crystal structure (PDB ID: 4EXZ). Addition of FR-1V to psHex (wt-Q108K/K40L/T51V/T53S/Y19W/R58Y; Supporting Information, Figure S3) led initially to the formation of a mixture of SB (λabs =378 nm) and PSB (λabs =600 nm), which equilibrated to a final ratio of the two species, as seen in Figure 1b. Conversion to the SB under in vitro conditions exhibits a second-order rate constant of 264m−1 s−1 at 23°C (Supporting Information, Figure S4). A short UV exposure (5 sec, ca. 365 nm) of this psHex-FR-1V complex (designated CrimFluor-1, CF-1) converts the thermodynamically equilibrated OFF state (λabs/em =378/445 nm, Figure 1b) to a photoactivated ON state (λabs/em =600/686 nm, Figure 1c). The two states can be interconverted repeatedly by UV (BP 300–400) and yellow light (LP 500) irradiation with good fatigue resistance (Figure 1d; Supporting Information, Figure S5). In contrast to the thermal conversion of the PSB (ON) to the SB (OFF), the light-assisted isomerization is about 50% faster (Figure 1e; Supporting Information, Figures S6S8). This light-triggered OFF-to-ON switchability enables spatiotemporal control of activation for the NIR fluorescence of CF-1.

Next, the performance of CF-1 as a no-wash live cell imaging system was investigated. psHex was expressed in HeLa, HEK293, and U2OS cell lines (Supporting Information, Figures S9, S10). Cells were stained with FR-1V for 5 min at 37°C and were imaged without any wash step. CF-1 retained its photoswitching ability in cellulo. A 1 s 405 nm laser excitation led to a 10-fold increase of the PSB fluorescence in the confocal NIR channel (LP650). The NIR signal specificity was measured by fusing EGFP on the N-terminus of psHex and examining the colocalization of green and NIR fluorescence. This was demonstrated with constructs localized in nucleus, cytosol, and plasma membrane, via C-terminal fused signal peptides.[11] In every triple-fused construct, the NIR emission demonstrated the same pixel specificity as that of EGFP (Supporting Information, Figure S11), confirming the purity of NIR fluorescence that is emitted from the activated CF-1 without any signal contamination from non-specifically labeled FR-1V. Furthermore, FR-1V elicits minimal cytotoxicity at the working concentration (2 μm; Supporting Information, Figure S12). Assessed by size exclusion chromatography, psHex is monomeric in solution up to millimolar concentration (20 mgmL−1; Supporting Information, Figure S13). This is advantageous, assuming the monomeric state dominates in cellular environments as well. Furthermore, CF-1 operates with less than 20% intensity loss across a range of physiologically relevant pHs (6 to 7.6; Supporting Information, Figure S14).

Having demonstrated proof of concept, we next examined the possibility to further engineer CF-1 as a fluorogenic tag without any residual PSB in the OFF state, so that a true dark NIR channel would be available before photoswitching. This would greatly increase the contrast for spatiotemporal imaging. We hypothesized that installation of more hydrophobic residues in the vicinity of the embedded FR-1V would destabilize the iminium (cationic species). This would have two potential consequences: 1) lessening or complete suppression of the residual PSB absorption in the OFF state, and 2) an accelerated ON-to-OFF thermal switching rate, by increasing the electrostatic penalty for maintaining a charged species. Several rounds of altering the psHex sequence led to psNona (psHex-Y58W/T29L/Q38L/Q128L; Supporting Information, Figure S3). As illustrated in Figures 1 f,g, the psNona-FR-1V complex (designated CF-2) showed negligible PSB absorption in its OFF state, while still displaying comparable absorption/emission maxima, QY, fatigue resistance, and the same labeling specificity to those of CF-1 (Figure 1, 2b,c; Supporting Information, Figure S5d; Table 1). A welcomed difference was noticed in a 6-fold increase in the in vitro ON-to-OFF thermal switching rate, and a 3-fold increased rate of complex formation for CF-2 in comparison to CF-1 (Table 1; Supporting Information, Figure S15). As shown (Figure 2a,d; Supporting Information, Figure S16), a completely dark NIR channel is observed before photoswitching (achieving a mean SBR of 46, a maximum SBR of 94, and 35-fold increase in fluorescence contrast) along with spatiotemporal control of the ON state demonstrated at single cell resolution (see Figure 1a, FR-1V chromophore for its photocycle summary). CF-2’s faster in cellulo ON-to-OFF thermal switching rate also makes multiple rounds of ON/OFF NIR fluorescence practical (Supporting Information, Figures S17 and S18). Finally, it should be noted that the NIR brightness of both CF-1 and CF-2 far exceeds that reported for other far-red/NIR FPs (Table 2),[3,21] with significantly improved Stokes shift.

Figure 2.

Figure 2.

a) Compartmentalized CF-2 labeling in HeLa cells, with N-terminal fused EGFP and C-terminal signal peptides. EGFP channel: BP 505–530. CF-2 channel: LP650. NLS=nuclear localization sequence. NES=nuclear export sequence. CAAX=prenylation tag. FR-1V=2 μm. Scale bars: 20 μm. b),c) Labeling specificity of nuclei-localized CF-2 in HeLa cells. b) Top left: EGFP channel; top right: CF-2_ON channel, circles and number indicating mean SBR (n=440); bottom: merged channels+DIC. c) Line profiles of fluorescence intensities in two channels along the blue arrow in (b). Scale bars: 20 μm. d) Confocal imaging of HeLa cells, expressing nuclei-localized hCRBPII fused with EGFP, stained with FR-1V (2 μm) for 5 min, no wash. Red channel: CF-2_ON. Following the arrows: before switch-on; 1st cell switch-on; 2nd cell switch-on; 3rd cell switch-on; whole field switch-on. Compare with green channel: reference EGFP. Scale bars: 10 μm. For channels in all images: EGFP, λex =488 nm (2.80 μW), BP 505–530; CF-2_ON, λswitch =405 nm (4.91 μW), λex =594 nm (1.63 μW), LP 650; DIC, λex =488 nm (2.80 μW).

Table 1:

Characteristics of CF-1 (psHex) and CF-2 (psNona).

Mutant SB λabs/λem PSB λabs/λem QY[a]SB QY[a]PSB Binding k [M−1 S−1][b] ON→OFF t1/2 [min][c]
psHex 378/445 600/686 0.46 0.16 264 7.4
psNona 382/440 604/684 0.52 0.13 759 1.2
[a]

Absolute quantum yields measured at pH 7.3.

[b]

Second-order rate constants of FR-1V and hCRBPII complexation.

[c]

Half-times were measured in dark (thermal conversion) at 23°C.

Table 2:

Comparison of CrimFluors with other far-red/NIR FPs.

mCherry mKate2 mNeptune IFP1.4[a] iRFP682[a] mIFP CF-1 (ON) CF-2 (ON)
Excitation peak [nm] 587 587 599 684 663 683 600 604
Emission peak [nm] 610 631 649 708 682 704 686 684
Fluorescence QY 0.22 0.39 0.18 0.07 0.11 0.08 0.16[b] 0.13[b]
εmax [M−1 cm−1] 72000 63000 57500 92000 90000 82000 50500 35700
Brightness (a.u.)[c] 15840 24570 10350 6440 9900 6560 8080 4641
ε635 [M−1 cm−1] 1000 7900 37550 27940
Φ(700–900 nm)[d] 0.04 0.05 0.07 0.05
Brightness in NIR [a.u.][e] 40 87[f] 395 2630 1400
Reference [21a] [21b,c] [21a] [3] [3] [3] this work this work
[a]

Dimer.

[b]

Absolute quantum yield measured in PBS (pH 7.3).

[c]

Calculated as the product of molar extinction coefficient and quantum yield.

[d]

Calculated from the emission fraction between 700 nm and 900 nm.

[e]

Calculated as the product of molar extinction coefficient at 635 nm and quantum yield in NIR-I (700–900 nm). Data of mCherry and mNeptune are reported in Ref. [21c].

[f]

Calculated from the brightness ratio (beyond 650 nm) to mCherry, as reported in Ref. [21b].

To our knowledge, CrimFluors are the first reported photoswitchable NIR tags that employ both a synthetic dye and a fusion protein. The design of CrimFluors accomplishes three complimentary goals towards a desirable imaging platform, namely: 1) the use of ICT capable fluorophores, 2) generation of a bathochromically-shifted PSB, and 3) the ability to photoactivatably turn ON and OFF the fluorescence signal. The use of ICT capable fluorophores leads to back-ground-free no-wash NIR fluorescence as a result of the large bathochromic shift of the fluorophore upon protonation of the imine, which happens only when bound to the engineered proteins. Tested in different cell lines, CF-1 and CF-2 can be turned to the ON state by a rapid 405-nm laser irradiation. Both have good photostability and a large Stoke shift, enabling data collection with a 650 nm long pass filter. If optimal NIR brightness is required, then CF-1 is a better choice. On the other hand, CF-2 offers a complete dark state with a faster ON-to-OFF thermal switching rate. CrimFluors can complement current systems for live cell imaging and have potential utility for bright deep-tissue imaging. With the CrimFluor platform as a starting point, further optimization of the complex (both fluorophore and protein) are underway to extend fluorescence lifetime of the emissive PSB species (to increase quantum yield) and enhance the photoswitching rates in both directions to better suit super-resolution microscopy.

Supplementary Material

Supporting Info

Acknowledgements

Generous support was provided by the NIH (GM101353).

Footnotes

Conflict of interest

The authors declare no conflict of interest.

Supporting information and the ORCID identification number(s) for the author(s) of this article can be found under: https://doi.org/10.1002/anie.201810065.

Contributor Information

Wei Sheng, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA).

Setare Tahmasebi Nick, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA).

Elizabeth M. Santos, Dow Performance Silicones 2200 W. Salzburg Rd, Midland, MI 48686 (USA)

Xinliang Ding, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA).

Jun Zhang, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA).

Chrysoula Vasileiou, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA).

James H. Geiger, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA)

Babak Borhan, Department of Chemistry, Michigan State University, E. Lansing, MI 48824 (USA).

References

  • [1].Kusumi A, Tsunoyama TA, Hirosawa KM, Kasai RS, Fujiwara TK, Nat. Chem. Biol. 2014, 10, 524–532. [DOI] [PubMed] [Google Scholar]
  • [2].Chudakov DM, Matz MV, Lukyanov S, Lukyanov KA, Physiol. Rev. 2010, 90, 1103–1163. [DOI] [PubMed] [Google Scholar]
  • 3.Chernov KG, Redchuk TA, Omelina ES, Verkhusha VV, Chem. Rev. 2017, 117, 6423–6446. [DOI] [PubMed] [Google Scholar]
  • 4.a) Weissleder R, Nat. Biotechnol. 2001, 19, 316–317; [DOI] [PubMed] [Google Scholar]; b) Hong GS, Antaris AL, Dai HJ, Nat. Biomed. Eng. 2017, 1, 0010. [Google Scholar]
  • 5.Zhou XX, Lin MZ, Curr. Opin. Chem. Biol. 2013, 17, 682–690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Landgraf D, Okumus B, Chien P, Baker TA, Paulsson J, Nat. Methods 2012, 9, 480–482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.a) Grimm JB, English BP, Chen J, Slaughter JP, Zhang Z, Revyakin A, Patel R, Macklin JJ, Normanno D, Singer RH, Lionnet T, Lavis LD, Nat. Methods 2015, 12, 244–250; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Grimm JB, Muthusamy AK, Liang Y, Brown TA, Lemon WC, Patel R, Lu R, Macklin JJ, Keller PJ, Ji N, Lavis LD, Nat. Methods 2017, 14, 987–994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dean KM, Palmer AE, Nat. Chem. Biol. 2014, 10, 512–523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.a) Plamont M-A, Billon-Denis E, Maurin S, Gauron C, Pimenta FM, Specht CG, Shi J, Quérard J, Pan B, Rossignol J, Moncoq K, Morellet N, Volovitch M, Lescop E, Chen Y, Triller A, Vriz S, Le Saux T, Jullien L, Gautier A, Proc. Natl. Acad. Sci. USA 2016, 113, 497–502; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Szent-Gyorgyi C, Schmidt BF, Creeger Y, Fisher GW, Zakel KL, Adler S, Fitzpatrick JAJ, Woolford CA, Yan Q, Vasilev KV, Berget PB, Bruchez MP, Jarvik JW, Waggoner A, Nat. Biotechnol. 2008, 26, 235–240. [DOI] [PubMed] [Google Scholar]
  • 10.Lang K, Chin JW, Chem. Rev. 2014, 114, 4764–4806. [DOI] [PubMed] [Google Scholar]
  • 11.Uttamapinant C, White KA, Baruah H, Thompson S, Fernández-Suárez M, Puthenveetil S, Ting AY, Proc. Natl. Acad. Sci. USA 2010, 107, 10914–10919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.a) Adams SR, Tsien RY, Nat. Protoc. 2008, 3, 1527; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Griffin BA, Adams SR, Tsien RY, Science 1998, 281, 269–272; [DOI] [PubMed] [Google Scholar]; c) Hoffmann C, Gaietta G, Zgrn A, Adams SR, Terrillon S, Ellisman MH, Tsien RY, Lohse MJ, Nat. Protoc. 2010, 5, 1666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.a) Chen Y, Clouthier CM, Tsao K, Strmiskova M, Lachance H, Keillor JW, Angew. Chem. Int. Ed. 2014, 53, 13785–13788; Angew. Chem. 2014, 126, 14005–14008; [DOI] [PubMed] [Google Scholar]; b) Chen Y, Tsao K, Acton SL, Keillor JW, Angew. Chem. Int. Ed. 2018, 57, 12390–12394; Angew. Chem. 2018, 130, 12570–12574. [DOI] [PubMed] [Google Scholar]
  • 14.Mizukami S, Hori Y, Kikuchi K, Acc. Chem. Res. 2014, 47, 247–256. [DOI] [PubMed] [Google Scholar]
  • 15.a) Blum G, Mullins SR, Keren K, Fonovič M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M, Nat. Chem. Biol. 2005, 1, 203–209; [DOI] [PubMed] [Google Scholar]; b) Nadler A, Schultz C, Angew. Chem. Int. Ed. 2013, 52, 2408–2410; Angew. Chem. 2013, 125, 2466–2469. [DOI] [PubMed] [Google Scholar]
  • 16.a) Devaraj NK, Weissleder R, Acc. Chem. Res. 2011, 44, 816–827; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Kormos A, Koehler C, Fodor EA, Rutkai ZR, Martin ME, Mezo G˝, E. A. Lemke, P. Kele, Chem. Eur. J. 2018, 24, 8841–8847. [DOI] [PubMed] [Google Scholar]
  • 17.Klymchenko AS, Acc. Chem. Res. 2017, 50, 366–375. [DOI] [PubMed] [Google Scholar]
  • 18.Wang W, Nossoni Z, Berbasova T, Watson CT, Yapici I, Lee KSS, Vasileiou C, Geiger JH, Borhan B, Science 2012, 338, 1340–1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.a) Berbasova T, Santos EM, Nosrati M, Vasileiou C, Geiger JH, Borhan B, ChemBioChem 2016, 17, 407–414; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Nosrati M, Berbasova T, Vasileiou C, Borhan B, Geiger JH, J. Am. Chem. Soc. 2016, 138, 8802–8808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kucherak OA, Didier P, Y. M8ly, A. S. Klymchenko, J. Phys. Chem. Lett. 2010, 1, 616–620. [Google Scholar]
  • 21.a) Bindels DS, Haarbosch L, van Weeren L, Postma M, Wieser KE, Mastop M, Aumonier S, Gotthard G, Royant A, Hink MA, Gadella TWJ, Nat. Methods 2017, 14, 53–56; [DOI] [PubMed] [Google Scholar]; b) Shcherbo D, Murphy CS, Ermakova GV, Solovieva EA, Chepurnykh TV, Shcheglov AS, Verkhusha VV, Pletnev VZ, Hazelwood KL, Roche PM, Lukyanov S, Zaraisky AG, Davidson MW, Chudakov DM, Biochem. J. 2009, 418, 567–574; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Shcherbo D, Shemiakina II, Ryabova AV, Luker KE, Schmidt BT, Souslova EA, Gorodnicheva TV, Strukova L, Shidlovskiy KM, Britanova OV, Zaraisky AG, Lukyanov KA, Loschenov VB, Luker GD, Chudakov DM, Nat. Methods 2010, 7, 827–829. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Info

RESOURCES